Literature DB >> 4904781

[L-asparaginase and leukemia].

E Grundmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4904781     DOI： 10.1007/bf01745766

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  59 in total

1.  Inhibitory effect of guinea pig serum on a number of new leukaemias in mice.

Authors:  E A BOYSE; L J OLD; E STOCKERT
Journal:  Nature       Date:  1963-05-25       Impact factor: 49.962

2.  Cytotoxicity of heterologous sera to normal and leukaemic human lymphocytes.

Authors:  R SCHREK
Journal:  Nature       Date:  1958-09-13       Impact factor: 49.962

3.  In vivo and in vitro studies of the action of guinea pig serum against the ascites form of the MurphySturm lymphosarcoma.

Authors:  H AINIS; H M KURTZ; P I KRAMER; H E WEIMER; R M RYAN; E JAMESON
Journal:  Cancer Res       Date:  1958-12       Impact factor: 12.701

4.  The effect of varying implant cell numbers on the inhibitory activity of guinea pig serum on Walker carcinosarcoma 256 in the rat.

Authors:  K S KWAK; E JAMESON; R M RYAN; H M KURTZ
Journal:  Cancer Res       Date:  1961-01       Impact factor: 12.701

5.  Inhibitory effects of normal guinea pig serum and immune rabbit serum on transplanted AKR lymphomas.

Authors:  J G KIDD; J E TODD
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

6.  Partial purification and antilymphoma activity of Serratia marcescens L-asparaginase.

Authors:  B Rowley; J C Wriston
Journal:  Biochem Biophys Res Commun       Date:  1967-07-21       Impact factor: 3.575

7.  Guinea pig serum inhibitory factor and asparaginase activity.

Authors:  R Hiramoto; C Tate; M Hamlin
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

8.  In vivo and in vitro effects of the L-asparaginase fraction of guinea pig serum on the 6C3HED ascites lymphosarcoma.

Authors:  L Borella; L J Journey; R Hiramoto
Journal:  Cancer Res       Date:  1966-12       Impact factor: 12.701

9.  Change in ribonuclease concentrations in L-asparaginase-treated lymphosarcomata.

Authors:  L T Mashburn; J C Wriston
Journal:  Nature       Date:  1966-09-24       Impact factor: 49.962

10.  New procedures for purification of L-asparaginase with high yield from Escherichia coli.

Authors:  J Roberts; G Burson; J M Hill
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490
View more
  6 in total

1.  [Immunosuppressive effect of L-asparaginase in the graft-versus-host reaction].

Authors:  H P Hobik
Journal:  Naturwissenschaften       Date:  1969-04

2.  [Amino acid concentration in plasma and blood cells during coli-L-asparaginase therapy].

Authors:  P Höcker; A Stacher; M Weiser
Journal:  Blut       Date:  1972-07

3.  [Detection of antibody blocking by L-asparaginase by means of the agar plaque technic].

Authors:  W P Madaus
Journal:  Klin Wochenschr       Date:  1970-02-15

4.  [Induction of immunologic tolerance against L-asparaginase from E. coli].

Authors:  U Hopf; W Land; H Furthmayr; R Timpl; W Brendel
Journal:  Klin Wochenschr       Date:  1971-06-15

5.  [Antigenicity of E. coli asparaginase in enzyme therapy of leukemia].

Authors:  H E Reis; W Braun; C G Schmidt
Journal:  Klin Wochenschr       Date:  1969-11-15

6.  [Effect of L-asparaginase from Escherichia coli on the phytohemagglutinin stimulated lymphocyte cultures].

Authors:  H Kirchner; S Bauer
Journal:  Klin Wochenschr       Date:  1970-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.